Allison Pack, MPHResearch Associate, Social and Behavioral Health Sciences
Areas of expertise
- Sexual and Reproductive Health
Projects & Resources
Should ongoing clinical trials identify an effective microbicide, the next challenge will be to ensure product access and use. Communication campaigns will play a critical role in generating demand and encouraging correct use.
FHI 360 developed and introduced innovative HIV prevention technologies — including microbicides and antiretrovirals — and worked with local partners to address the need for HIV prevention options, particularly for women.
Published Research/** * @file * Unformatted override for published research. * Using the same markup as "project" because it's the same */ ?>
Positioning microbicides for HIV prevention in Kenya: A case study
Ryan E, Bockh E, Tolley EE, Pack AP, Mackenzie C, Olawo A, Githuka G.
Soc Mar Q 2015 Jun; 21 (2): 100-14. [Journal Impact Factor: n/a]
This case study describes the experience of developing communication messages and materials to position microbicide gel — a product still in clinical trials — for HIV prevention in Kenya. The project confirmed that marketing microbicides to women in a wide variety of sexual contexts —and gaining the support of male partners — will be critical for avoiding stigmatization of the product. It also confirmed that the positioning of the product can impact interest in using microbicides and that in-depth counseling will be critical for ensuring correct use.